» Articles » PMID: 12358767

Up-regulation of the PACAP Type-1 Receptor (PAC1) Promoter by Neurotrophins in Rat PC12 Cells and Mouse Cerebellar Granule Cells Via the Ras/mitogen-activated Protein Kinase Cascade

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2002 Oct 3
PMID 12358767
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The pituitary adenylate cyclase-activating polypeptide type-1 receptor (PAC1) has been involved in the survival and differentiation of neuroblasts during development. This study examined the effects of various neurotrophins on the activity of the mouse PAC1 promoter/luciferase reporter constructs in rat PC12 cells and in 8-day-old mouse cerebellar granule cells. In PC12 cells, both differentiating factors such as nerve growth factor (NGF) and mitogens such as epidermal growth factor (EGF) and insulin growth factor-1 (IGF-1) up-regulated PAC1 promoter activity by 2-4-fold in a concentration-dependent manner. Although PACAP differentiated the PC12 cells, it had no effect on the PAC1 promoter and antagonized the stimulatory effect of NGF. In cerebellar granule cells, IGF-1 and brain-derived neurotrophic factor (BDNF) also stimulated the activity of the PAC1 promoter. NGF and IGF-1 increased endogenous PAC1 mRNA levels, and the NGF-induced up-regulation is the result of an increase in transcription from PAC1 promoter instead of an increase in mRNA stability. The mitogen-activated protein kinase (MAPK) kinase inhibitor, PD98059, prevented the transcriptional effects both in PC12 and cerebellar granule cells. Moreover, expression of dominant-negative Ras protein in PC12 cells also prevented the NGF effect. Our results show that the PAC1 promoter can be up-regulated by diverse neurotrophins via an MAPK-dependent pathway and suggest a role for the Ras protein.

Citing Articles

PACAP/PAC1 Expression and Function in Micturition Pathways.

Ojala J, Tooke K, Hsiang H, Girard B, May V, Vizzard M J Mol Neurosci. 2018; 68(3):357-367.

PMID: 30259317 PMC: 6437024. DOI: 10.1007/s12031-018-1170-7.


PACAP/Receptor System in Urinary Bladder Dysfunction and Pelvic Pain Following Urinary Bladder Inflammation or Stress.

Girard B, Tooke K, Vizzard M Front Syst Neurosci. 2017; 11:90.

PMID: 29255407 PMC: 5722809. DOI: 10.3389/fnsys.2017.00090.


Alteration of the PAC1 Receptor Expression in the Basal Ganglia of MPTP-Induced Parkinsonian Macaque Monkeys.

Feher M, Gaszner B, Tamas A, Gil-Martinez A, Fernandez-Villalba E, Herrero M Neurotox Res. 2017; 33(4):702-715.

PMID: 29230633 DOI: 10.1007/s12640-017-9841-7.


Intravesical PAC1 Receptor Antagonist, PACAP(6-38), Reduces Urinary Bladder Frequency and Pelvic Sensitivity in NGF-OE Mice.

Girard B, Malley S, Mathews M, May V, Vizzard M J Mol Neurosci. 2016; 59(2):290-9.

PMID: 27146136 PMC: 5252828. DOI: 10.1007/s12031-016-0764-1.


PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in schwann cell-like cultures.

Castorina A, Waschek J, Marzagalli R, Cardile V, Drago F PLoS One. 2015; 10(2):e0117799.

PMID: 25658447 PMC: 4319891. DOI: 10.1371/journal.pone.0117799.